Cullen Investment Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.8M Buy
7,730
+37
+0.5% +$12.7K 0.34% 62
2026
Q1
$2.71M Sell
7,693
-20
-0.3% -$7.13K 0.36% 66
2025
Q4
$2.52M Buy
7,713
+5
+0.1% +$1.59K 0.33% 71
2025
Q3
$2.3M Sell
7,708
-477
-6% -$138K 0.3% 65
2025
Q2
$2.29M Sell
8,185
-131
-2% -$37.1K 0.32% 64
2025
Q1
$2.59M Sell
8,316
-266
-3% -$78.5K 0.39% 62
2024
Q4
$2.24M Sell
8,582
-48
-0.6% -$14.2K 0.33% 64
2024
Q3
$2.78M Buy
8,630
+23
+0.3% +$7.52K 0.41% 56
2024
Q2
$2.69M Sell
8,607
-77
-0.9% -$22.6K 0.43% 55
2024
Q1
$2.4M Sell
8,684
-5
-0.1% -$1.46K 0.38% 61
2023
Q4
$2.5M Buy
+8,689
New +$2.37M 0.44% 55

Other funds holding AMGN

Cullen Investment Group's AMGN Position: Q2 2026 in Review

Cullen Investment Group increased its Amgen (AMGN) stake by 0.48% in Q2 2026, buying an estimated $12.7K and bringing the position to 7,730 shares worth $2.8M. The position accounts for 0.34% of the portfolio, ranked #62.

Cullen Investment Group first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,353 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cullen Investment Group held 7,730 shares of Amgen worth $2.8M as of Q2 2026.
  • Cullen Investment Group bought 37 Amgen shares in Q2 2026, an estimated $12.7K.
  • Amgen made up 0.34% of Cullen Investment Group's portfolio in Q2 2026, its #62 holding.
  • Cullen Investment Group first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 1,353 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cullen Investment Group's 13F filing for Q2 2026, filed 9 Jul 2026.